Immunic IMUX
NASDAQ IMUX
$7.48 0.00 (0.00%)
As of: Oct 22, 2026 · 11:29 AM EDT

Immunic (IMUX) Goodwill impairment charges (2022)

Updated

Immunic's Goodwill impairment charges came in at $33 million for Q4 2022.

Analysis

Immunic (IMUX) Goodwill impairment charges (2022) Analysis & Trends

For FY2022, Immunic's Goodwill impairment charges was $32.97 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,176.80 Bn 1,145.39 Bn 19.71 Bn
2 Johnson & Johnson 639.81 Bn 558.34 Bn 17.26 Bn
3 AbbVie 503.28 Bn 476.39 Bn 12.70 Bn
4 Merck 376.70 Bn 331.08 Bn 12.21 Bn
5 Novartis Ag 303.61 Bn 267.60 Bn 11.24 Bn
6 Astrazeneca 268.37 Bn 242.05 Bn 12.86 Bn
7 Amgen 242.34 Bn 197.74 Bn 7.24 Bn
8 Gilead Sciences 193.58 Bn 167.78 Bn 6.22 Bn
9 Pfizer 172.88 Bn 119.53 Bn 10.94 Bn
10 Immunic 318.00 Mn -74.34 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 33.00 Mn
API Access

Immunic Goodwill impairment charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=goodwill-impairment-charges&ticker=IMUX&period=max&api_key=YOUR_API_KEY